Matching slides 10,645
Current window 3,001-3,030
Pages 355
Rows per page 30
Component: Quoteclear collectionreset all

Component

3,001-3,030 of 10,645

filter-aware
29
The slide uses a direct quote from a 20-F filing to contrast with a contractual requirement, alleging management dishonesty.iQIYI, Inc. (IQ) · Wolfpack Research
Research note Short seller Beat · The Victory2 hits
05
The slide uses patient anecdotes and FDA data to argue against the viability and safety of the Inspire system.Inspire Medical Systems, Inc. (INSP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter2 hits
08
The slide uses a table to highlight missed performance targets and quotes from executives to contrast with actual financial outcomes.GTT Communications, Inc. (GTT) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter2 hits
09
The slide uses expert testimony and competitor insight to build a bearish thesis on GTT's operational health.GTT Communications, Inc. (GTT) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Pattern Hunter2 hits
05
Includes two quotes from industry figures to support the argument that recoverability testing is standard and inexpensive.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Villain CritiqueLoop · Zoom In2 hits
06
Uses quotes from Randall Atkins (METC CEO) and Rick Pobjoy (AR3 Founder) to frame the contradiction.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
17
This is a research note page from Wolfpack Research, focusing on corporate governance and disclosure failures.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 2 hits
90
The slide uses expert quotes to undermine the technical viability of the competitor's product.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
91
The slide uses direct quotes from an industry expert to frame Twist's technology as fundamentally flawed and prone to the same failure modes as previous market participants.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
92
The slide uses a Q&A format with an 'IDT ex-regional sales manager' to build a narrative of a 'fatal flaw'.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
94
Uses expert testimony to undermine the company's operational efficiency claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
96
The slide uses a quote from an industry executive to validate the thesis of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
98
The slide uses a Q&A format to present expert testimony as a critique of the target company's core technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
102
Uses Q&A format to present expert testimony as evidence of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
103
Uses Q&A format to frame expert testimony as a critique of the company's core technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
104
The slide uses a Q&A format to highlight expert skepticism regarding Twist's unit economics.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
106
The slide uses a 'villain critique' approach by citing external experts to undermine the company's technological claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
119
The slide uses excerpts from an S-1/A filing to support the claim of misclassification.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
148
The slide uses a Q&A format to expose a contradiction between company marketing and customer experience.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
159
Uses direct quotes to undermine the company's technical capabilities.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
163
The slide uses direct quotes from a major genomics center and an ex-IDT manager to build a case against Twist's product reliability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
164
The slide uses direct quotes from a customer to undermine the company's quality reputation.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
166
The slide uses direct quotes from an IDT ex-regional sales manager to undermine the target company's marketing claims.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
169
The slide uses direct quotes from a competitor to undermine the target company's credibility.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
180
The slide uses a Q&A format to validate the thesis that Twist is a 'race to the bottom' competitor.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
182
The slide uses direct quotes from a former competitor employee to frame Twist's strategy as low-quality/low-cost vs. the industry standard of quality-focused value propositions.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
190
The slide uses a Q&A format to present primary research findings from Scorpion Capital.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
193
The slide uses highlighted text to emphasize key negative sentiment regarding Twist's market position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
195
Uses expert testimony to frame the company as a commodity player in a niche market.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
204
The slide uses highlighted text to emphasize key competitive advantages (speed, delivery times).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits